Example: Heart Attack

Clinical Trials Sponsored by ICON Clinical Research

Total 47 results

NCT04209543

Recruiting

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Conditions: Vasomotor Symptoms; Menopausal Symptoms
NCT04090957

Recruiting

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

Conditions: Vasomotor Symptoms; Menopausal Symptoms
NCT03849469

Recruiting

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Conditions: Melanoma; Cervical Carcinoma; Pancreatic Carcinoma; Triple Negative Breast Cancer; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Nasopharyngeal Carcinoma; Renal Cell Carcinoma; Non-small Cell Lung Carcinoma; Small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Advanced or Metastatic Solid Tumors; Prostate Carcinoma; MSI-H; Mismatch Repair Deficiency; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Intrahepatic Cholangiocarcinoma
NCT03806179

Recruiting

Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL

Conditions: Non Hodgkin Lymphoma; Follicular Lymphoma; Relapsed Follicular Lymphoma
NCT03744910

Recruiting

Interleukin 6 Blockade Modifying Antibody-Mediated Graft Injury and Estimated Glomerular Filtration Rate (eGFR) Decline

Conditions: Antibody-mediated Rejection
NCT03216486

Withdrawn

An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta

Conditions: Osteogenesis Imperfecta
NCT03185832

Active, not recruiting

Heart Failure and Sudden Cardiac Death Japan Registry

Conditions: Heart Failure; Arrhythmias, Cardiac; Sudden Cardiac Death
NCT03118570

Active, not recruiting

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Conditions: Osteogenesis Imperfecta, Type I; Osteogenesis Imperfecta Type III; Osteogenesis Imperfecta Type IV
NCT03060746

Completed

Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects

Conditions: Helicobacter Pylori Infection; Gastric Ulcer; Nausea; Abdominal Pain; Weight Loss; Stomach Ulcer; Loss of Appetite; Bloating
NCT03060733

Completed

Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects

Conditions: Helicobacter Pylori Infection; Gastric Ulcer; Nausea; Abdominal Pain; Weight Loss; Stomach Ulcer; Loss of Appetite; Bloating
NCT02924402

Recruiting

Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies

Conditions: B-cell Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia
NCT02763319

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Conditions: Diffuse Large B-cell Lymphoma
NCT02730312

Recruiting

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

Conditions: Acute Myelogenous Leukemia; B-cell Acute Lymphoblastic Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Chronic Myeloid Leukemia, Blast Crisis
NCT02727699

Completed

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Conditions: Dementia, Alzheimer Type
NCT02351635

Completed

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

Conditions: Inflammatory Bowel Disease; Irritable Bowel Syndrome
NCT02074579

Completed

A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

Conditions: Irritable Bowel Syndrome in Females
NCT02065336

Terminated

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Conditions: Hepatitis B, Chronic
NCT02047344

Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

Conditions: Non-small Cell Lung Cancer Stage IV
NCT01809912

Terminated

Safety Study of MG1102 in Patients With Solid Tumors

Conditions: Solid Tumors
NCT01796171

Recruiting

A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma

Conditions: Non-Hodgkin Lymphoma; Follicular Lymphoma
NCT01572909

Completed

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Conditions: Reperfusion Injury; STEMI
NCT01545076

Completed

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy; Polyradiculoneuropathy
NCT01453608

Completed

A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency

Conditions: Iron Deficiency; Chronic Heart Failure
NCT01350362

Completed

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Conditions: Alzheimer's Disease
NCT01244750

Unknown status

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Conditions: Chronic Myeloid Leukemia